European Union parliamentarians and member states reached a provisional deal on May 12 to strengthen their essential medicines supply by increasing domestic production and reducing reliance on imports.
The agreement is a step forward for the Critical Medicines Act, proposed by the European Commission last year, and targets supply-chain vulnerabilities affecting about 270 medicines considered critical to the 27-nation bloc’s health security.
